512600 — Astal Laboratories Balance Sheet
0.000.00%
- IN₹845.39m
- IN₹809.51m
- IN₹236.48m
- 21
- 51
- 58
- 38
Annual balance sheet for Astal Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.145 | 0.313 | 0.183 | 0.844 | 60.8 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 51.1 | 51.5 | 51.3 | 31.7 | 158 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 51.3 | 51.8 | 51.5 | 61.1 | 267 |
Net Property, Plant And Equipment | 0.686 | 0.531 | 0.135 | 0.056 | 6.9 |
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 52.7 | 53.1 | 52.3 | 99.1 | 366 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.772 | 1.3 | 0.678 | 47.3 | 130 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 1.01 | 1.32 | 0.689 | 47.3 | 133 |
Common Stock | |||||
Other Equity | |||||
Total Equity | 51.7 | 51.8 | 51.6 | 51.8 | 233 |
Total Liabilities & Shareholders' Equity | 52.7 | 53.1 | 52.3 | 99.1 | 366 |
Total Common Shares Outstanding |